2.4 C
Munich
Tuesday, February 7, 2023
- Advertisement -spot_img

TAG

cystic fibrosis

Vertex’s (NASDAQ: VRTX) SYMKEVI Receive Approval From European Commission

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has disclosed that it has received authorization from the European Commission to start the treatment of patients ages six...

Latest news

- Advertisement -spot_img